Ny teknologi brukt i fiskevaksiner mot sykdommer uten funksjonelle vaksiner

Offentlig prosjektsammendrag

Previwo has a novel technological approach to bacterial disease vaccine protocols. The company is presently engaged in proving that technology to tackle two economically significant diseases; Salmonid Rickettsial Septicaemia (SRS) and Tenacibaculosis affecting farmed salmon globally. The pathogenesis of either disease is not fully understood, but it does appear that the bacteria dynamically changes their pathogenic repertoire depending on its micro-ecological environment. The broad-based approach to inclusion antigens produced in a manufacturing vaccine protocol that mimics the conditions and tissue tropism in the body where the pathogens propagate is the main discovery of Previwo’ s new technology. We will develop vaccines through the research and development phase to address these serious and economically devastating bacterial fish diseases and broaden the company’s strategic focus in preventative health products.